Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 11/2003

01-11-2003 | Article

Declining Incidence of AIDS and Increasing Prevalence of AIDS Presenters Among AIDS Patients in Italy

Authors: B. Castelnuovo, E. Chiesa, S. Rusconi, F. Adorni, M. Bongiovanni, S. Melzi, P. Cicconi, F. Tordato, L. Meroni, T. Bini, A. d’Arminio Monforte

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 11/2003

Login to get access

Abstract

Presented here are the results of a cohort study conducted on 3,483 consecutive HIV/AIDS patients between January 1993 and December 2000 to determine trends in AIDS incidence and presentation. The incidence of AIDS was calculated in the general population and examined further according to gender, age (≤ or >49 years), and heterosexual behaviour as a risk factor for HIV. Multivariate analysis was used to identify variables associated with AIDS presenters (defined as patients diagnosed with AIDS within 1 month of the first HIV-positive test). The numbers of patients with AIDS classified as (i) AIDS presenters, (ii) known HIV-positive patients on antiretroviral treatment, and (iii) known HIV-positive patients not receiving antiretroviral treatment were calculated. The overall incidence of AIDS decreased over time, mainly due to the lower number of patients on antiretroviral treatment developing AIDS. Factors associated with a higher risk of being an AIDS presenter were male gender and year of HIV diagnosis. Among patients with AIDS, the proportion of AIDS presenters increased from 13.8% prior to 1997 (when protease inhibitors were introduced in Italy) to 32.5% after 1997. Variables predictive of being an AIDS presenter were male gender, age at diagnosis, and AIDS diagnosis in the years 1997–2000. Heterosexuals had a higher risk of being AIDS presenters and a lower risk of being HIV-positive and not receiving antiretroviral treatment than intravenous drug users. In Italy, AIDS occurs mainly in subjects unaware of their HIV status (especially males, the elderly, and those infected heterosexually) or in patients refusing antiretroviral therapy (mainly intravenous drug users who do not refer to specialised centres).
Literature
1.
go back to reference Palella FG, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338:853–860PubMed Palella FG, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338:853–860PubMed
2.
go back to reference Mouton Y, Alfandari S, Valette M, Cartier F, Dellamonica P, Humbert G, Lang JM, Massip P, Mechali D, Leclercq P, Modai J, Portier H Federation Nationale des Centres de Lutte contre le SIDA (1997) Impact of protease inhibitors on AIDS-defining events and hospitalization in 10 French AIDS reference centers. AIDS 11:F101–F105PubMed Mouton Y, Alfandari S, Valette M, Cartier F, Dellamonica P, Humbert G, Lang JM, Massip P, Mechali D, Leclercq P, Modai J, Portier H Federation Nationale des Centres de Lutte contre le SIDA (1997) Impact of protease inhibitors on AIDS-defining events and hospitalization in 10 French AIDS reference centers. AIDS 11:F101–F105PubMed
3.
go back to reference Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d’Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. Eurosida Study Group. Lancet 352:1725–1730PubMed Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, d’Arminio Monforte A, Yust I, Bruun JN, Phillips AN, Lundgren JD (1998) Changing patterns of mortality across Europe in patients infected with HIV-1. Eurosida Study Group. Lancet 352:1725–1730PubMed
4.
go back to reference Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997) Positive effects of combined antiretroviral therapy on CD4+ cell homeostasis and function in advanced HIV disease. Science 277:112–116CrossRefPubMed Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997) Positive effects of combined antiretroviral therapy on CD4+ cell homeostasis and function in advanced HIV disease. Science 277:112–116CrossRefPubMed
5.
go back to reference Hammer SC, Squires KE, Hughes MD (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell count of 200 per cubic millimeter or less. N Engl J Med 337:725–733CrossRefPubMed Hammer SC, Squires KE, Hughes MD (1997) A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell count of 200 per cubic millimeter or less. N Engl J Med 337:725–733CrossRefPubMed
6.
go back to reference Staszewsky S, Morales-Ramirez J, Tashima K (1999) Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. N Engl J Med 341:1865–1873CrossRefPubMed Staszewsky S, Morales-Ramirez J, Tashima K (1999) Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. N Engl J Med 341:1865–1873CrossRefPubMed
7.
go back to reference Yarchoan R, Venzon DJ, Pluda JM, Lietzau J, Wyvill KM, Tsiatis AA, Steinberg SM, Broder S (1991) CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 115:184–189PubMed Yarchoan R, Venzon DJ, Pluda JM, Lietzau J, Wyvill KM, Tsiatis AA, Steinberg SM, Broder S (1991) CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med 115:184–189PubMed
8.
go back to reference O’ Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, Rubin M, Simberkoff MS, Hamilton JD (1996) Changes in plasma HIV-RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. New Engl J Med 334:426–431CrossRefPubMed O’ Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, Rubin M, Simberkoff MS, Hamilton JD (1996) Changes in plasma HIV-RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. New Engl J Med 334:426–431CrossRefPubMed
9.
go back to reference Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF (1991) Predictive value of CD4+ lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr Human Retrovir 4:770–776 Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF (1991) Predictive value of CD4+ lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr Human Retrovir 4:770–776
10.
go back to reference Finkelstein DM, Williams PL, Molemberghs G, Feinberg J, Powderly WG, Kahn J, Dolin R, Cotton D (1996) Patterns of opportunistic infection in patients with HIV infection. J Acquir Immune Defic Syndr Human Retrovir 12:38–45 Finkelstein DM, Williams PL, Molemberghs G, Feinberg J, Powderly WG, Kahn J, Dolin R, Cotton D (1996) Patterns of opportunistic infection in patients with HIV infection. J Acquir Immune Defic Syndr Human Retrovir 12:38–45
11.
go back to reference Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD (2001) Understanding delay to medical care for HIV infection: the long-term non presenter. AIDS 15:77–85CrossRefPubMed Samet JH, Freedberg KA, Savetsky JB, Sullivan LM, Stein MD (2001) Understanding delay to medical care for HIV infection: the long-term non presenter. AIDS 15:77–85CrossRefPubMed
12.
go back to reference Girardi E, Sampaolesi A, Gentile M, Nurra G, Ippolito G (2000) Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy. J Acquir Immune Defic Syndr Human Retrovir 25:71–76CrossRef Girardi E, Sampaolesi A, Gentile M, Nurra G, Ippolito G (2000) Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy. J Acquir Immune Defic Syndr Human Retrovir 25:71–76CrossRef
13.
go back to reference Centers for Disease Control (1992) 1993 Revised system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41:9–12 Centers for Disease Control (1992) 1993 Revised system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41:9–12
14.
go back to reference Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, Rickenbach M, Malinverni R, Vernazza P, Battegay M (1997) Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 315:1194–1199PubMed Egger M, Hirschel B, Francioli P, Sudre P, Wirz M, Flepp M, Rickenbach M, Malinverni R, Vernazza P, Battegay M (1997) Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. BMJ 315:1194–1199PubMed
15.
go back to reference Rezza G, De Rose A, Dorrucci M, Arpino C, Serafin I (1993) Declining prevalence of HIV infection among injecting drug users entering drug treatment in Italy: 1990–1991. Eur J Epidemiol 9:663–666PubMed Rezza G, De Rose A, Dorrucci M, Arpino C, Serafin I (1993) Declining prevalence of HIV infection among injecting drug users entering drug treatment in Italy: 1990–1991. Eur J Epidemiol 9:663–666PubMed
16.
go back to reference Puro V, D’Ubaldo C, Aloisi MS, Sherr L, Ippolito G (1998) Temporal trends in reasons for and results of HIV-testing among women in Rome, Italy. Eur J Epidemiol 14:443–447 Puro V, D’Ubaldo C, Aloisi MS, Sherr L, Ippolito G (1998) Temporal trends in reasons for and results of HIV-testing among women in Rome, Italy. Eur J Epidemiol 14:443–447
17.
go back to reference USPHS/IDSA (2001) Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. July 2001. A summary. HIV Clin Trials 2:493–554PubMed USPHS/IDSA (2001) Guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. July 2001. A summary. HIV Clin Trials 2:493–554PubMed
18.
go back to reference Wortley PM, Chu SY, Diaz T, Ward JW, Doyle B, Davidson AJ, Checko PJ, Herr M, Conti L, Fann SA (1995) HIV testing patterns: where, why and when were persons with AIDS tested for HIV. AIDS 9:487–492PubMed Wortley PM, Chu SY, Diaz T, Ward JW, Doyle B, Davidson AJ, Checko PJ, Herr M, Conti L, Fann SA (1995) HIV testing patterns: where, why and when were persons with AIDS tested for HIV. AIDS 9:487–492PubMed
19.
go back to reference Porter K, Wall PG, Evans BG (1993) Factors associated with lack of awareness of HIV infection before diagnosis of AIDS. BMJ 307:20–23PubMed Porter K, Wall PG, Evans BG (1993) Factors associated with lack of awareness of HIV infection before diagnosis of AIDS. BMJ 307:20–23PubMed
20.
go back to reference Couturier E, Schwoebel V, Michon C, Hubert JB, Delmas MC, Morlat P, Boue F, Simonpoli AM, Dabis F, Brunet JB (1998) Determinants of delayed diagnosis of HIV infection in France, 1993–1995. AIDS 12:795–800CrossRefPubMed Couturier E, Schwoebel V, Michon C, Hubert JB, Delmas MC, Morlat P, Boue F, Simonpoli AM, Dabis F, Brunet JB (1998) Determinants of delayed diagnosis of HIV infection in France, 1993–1995. AIDS 12:795–800CrossRefPubMed
21.
go back to reference Poznansky MC, Coker R, Skinner C, Hill A, Bailey S, Whitaker L, Renton A, Weber J (1995) HIV positive patients first presenting with an AIDS defining illness: characteristics and survival. BMJ 311:156–158PubMed Poznansky MC, Coker R, Skinner C, Hill A, Bailey S, Whitaker L, Renton A, Weber J (1995) HIV positive patients first presenting with an AIDS defining illness: characteristics and survival. BMJ 311:156–158PubMed
22.
go back to reference Kaldor JM, French MA (1993) When do patients present with HIV infection? Med J Aust 158:37–38PubMed Kaldor JM, French MA (1993) When do patients present with HIV infection? Med J Aust 158:37–38PubMed
Metadata
Title
Declining Incidence of AIDS and Increasing Prevalence of AIDS Presenters Among AIDS Patients in Italy
Authors
B. Castelnuovo
E. Chiesa
S. Rusconi
F. Adorni
M. Bongiovanni
S. Melzi
P. Cicconi
F. Tordato
L. Meroni
T. Bini
A. d’Arminio Monforte
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 11/2003
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-003-1038-8

Other articles of this Issue 11/2003

European Journal of Clinical Microbiology & Infectious Diseases 11/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.